Tim Guilliams

Tech entrepreneur and CEO of Healx.ai

Tim Guilliams is a prominent tech entrepreneur and the Co-founder and Chief Executive of Healx, a company focused on using artificial intelligence to accelerate the discovery and development of treatments for rare diseases. He has been recognized for his contributions to the field, being listed in The Sunday Times Maserati 100 and The Telegraph’s Tech 100 in 2019, as well as being named one of In Vivo’s 30 Rising Leaders in Life Sciences in 2020.1 3

In addition to his role at Healx, Guilliams serves as an Entrepreneurship Fellow at the Cambridge Judge Business School since January 2020. His work there involves supporting entrepreneurial talent development within the Cambridge ecosystem.1 3 He is also a founding trustee and former chair of the Cambridge Rare Disease Network, which aims to enhance dialogue and awareness around rare diseases.2 3

Guilliams holds a PhD in Biophysical Neuroscience from the University of Cambridge, where he researched antibody fragments for therapeutic applications in Parkinson's disease. He also earned an MEng in Bio-Engineering from the University of Brussels prior to his doctoral studies.2 3

Experience

Co-founder, CEO at Healx Ltd (April 2014 - Present)

Entrepreneurship Fellow at Cambridge Judge Business School (January 2020 - Present); Founding Director and Trustee at Cambridge Rare Disease Network (March 2015 - March 2023); Junior Associate Fellow at Centre for Science and Policy (2010 - April 2015)

Education

PhD in Biophysical Neuroscience from University of Cambridge (2009 - 2013); Bachelor & Masters in Bio-Engineering from VUB (2003 - 2008); 3rd Bachelor in Bio-Engineering from Universidad de Murcia (2005 - 2006)